Heparin binding EGF-like growth factor (HB-EGF), which is a member of epidermal growth factor (EGF) family member and a ligand for EGF-receptor (EGFR) [1], is involved in various pathophysiological processes including atherosclerosis and cancer development [2–6]. Here, HBEGF is linked to cancer.